» Articles » PMID: 23687943

Body Mass Index and Musculoskeletal Pain: is There a Connection?

Overview
Publisher Biomed Central
Date 2013 May 22
PMID 23687943
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Back pain is one of the most common complaints that patients report to physicians and two-thirds of the population has an elevated body mass index (BMI), indicating they are either overweight or obese. It was once assumed that extra body weight would stress the low back and lead to pain, however, researchers have reported inconsistencies association between body weight and back pain. In contrast, more recent studies do indicate that an elevated BMI is associated with back pain and other musculoskeletal pain syndromes due to the presence of a chronic systemic inflammatory state, suggesting that the relationship between BMI and musculoskeletal pains be considered in more detail.

Objective: To describe how an elevated BMI can be associated with chronic systemic inflammation and pain expression. To outline measurable risk factors for chronic inflammation that can be used in clinical practice and discuss basic treatment considerations.

Discussion: Adiposopathy, or "sick fat" syndrome, is a term that refers to an elevated BMI that is associated with a chronic systemic inflammatory state most commonly referred to as the metabolic syndrome. The best available evidence suggests that the presence of adiposopathy determines if an elevated BMI will contribute to musculoskeletal pain expression. It is not uncommon for physicians to fail to identify the presence of adiposopathy/metabolic syndrome.

Conclusion: Patients with an elevated BMI should be further examined to identify inflammatory factors associated with adiposopathy, such as the metabolic syndrome, which may be promoting back pain and other musculoskeletal pain syndromes.

Citing Articles

Impact of Musculoskeletal Pain on Health-Related Quality of Life Among Adults in Saudi Arabia.

Hashem M, Almohaini R, Alharbi T, Aljurfi M, Alzmamy S, Alhussainan F Cureus. 2024; 16(3):e57053.

PMID: 38681335 PMC: 11051673. DOI: 10.7759/cureus.57053.


Efficacy of chronic neck pain self-treatment using press needles: a randomized controlled clinical trial.

Horike K, Ukezono M Front Pain Res (Lausanne). 2024; 5:1301665.

PMID: 38586186 PMC: 10995221. DOI: 10.3389/fpain.2024.1301665.


Adults with excess weight or obesity, but not with overweight, report greater pain intensities than individuals with normal weight: a systematic review and meta-analysis.

Garcia M, Corrales P, Huerta M, Czachorowski M, Lopez-Miranda V, Medina-Gomez G Front Endocrinol (Lausanne). 2024; 15:1340465.

PMID: 38510698 PMC: 10950917. DOI: 10.3389/fendo.2024.1340465.


Lifestyle risk factors of self-reported fibromyalgia in the Norwegian Women and Cancer (NOWAC) study.

Benebo F, Lukic M, Jakobsen M, Braaten T BMC Public Health. 2023; 23(1):1967.

PMID: 37821848 PMC: 10566054. DOI: 10.1186/s12889-023-16773-7.


The potential of a multimodal digital care program in addressing healthcare inequities in musculoskeletal pain management.

Areias A, Molinos M, Moulder R, Janela D, Scheer J, Bento V NPJ Digit Med. 2023; 6(1):188.

PMID: 37816899 PMC: 10564877. DOI: 10.1038/s41746-023-00936-2.


References
1.
Hypponen E, Boucher B, Berry D, Power C . 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2007; 57(2):298-305. DOI: 10.2337/db07-1122. View

2.
Sommer C, Birklein F . Resolvins and inflammatory pain. F1000 Med Rep. 2011; 3:19. PMC: 3186038. DOI: 10.3410/M3-19. View

3.
Abate M, Schiavone C, Pelotti P, Salini V . Limited joint mobility (LJM) in elderly subjects with type II diabetes mellitus. Arch Gerontol Geriatr. 2010; 53(2):135-40. DOI: 10.1016/j.archger.2010.09.011. View

4.
Chandran M, Phillips S, Ciaraldi T, Henry R . Adiponectin: more than just another fat cell hormone?. Diabetes Care. 2003; 26(8):2442-50. DOI: 10.2337/diacare.26.8.2442. View

5.
Rethorst C, Toups M, Greer T, Nakonezny P, Carmody T, Grannemann B . Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry. 2012; 18(10):1119-24. PMC: 3511631. DOI: 10.1038/mp.2012.125. View